Workshop on
Workshop on
AI for New Drug Modalities
AI for New Drug Modalities
at NeurIPS 2024 in Vancouver, British Columbia, Canada (12/15)
at NeurIPS 2024 in Vancouver, British Columbia, Canada (12/15)
Embedded Files
Overviews
Overviews
The primary objective of this workshop is to bridge the gap between AI and emerging drug modalities, such as gene, RNA, and cell therapies.
The primary objective of this workshop is to bridge the gap between AI and emerging drug modalities, such as gene, RNA, and cell therapies.
PROTEIN DESIGN COMPETITION (SUBMISSION, DEADLINE 11/4, EOD)
SPEAKERS AND PANELISTS
SPEAKERS AND PANELISTS
Le Cong (Stanford university)
Eric Xing (MBZUAI)
Georg Seelig (University of Washington)
Jennifer Listgarten (UC Berkeley)
Anima Anandkumar (Caltech)
Ali Madani (Profluent Bio)
Grace Zheng (ArsenalBio)
Edith Hessel (Relation therapeutics)
Kyunghyun Cho (NYU/Rrecision Design)
Ryan Peckner (Seismic Therapeutic)
Lindsay Edwards (Relation therapeutics)
Janet Paulsen (NVIDIA)
Bruno Trentini (NVIDIA)
ORGANIZERS
ORGANIZERS
Masatoshi Uehara (Genentech)
Mengdi Wang (Princeton)
Su-In Lee (University of Washington)
Le Song (BioMap, MBZUAI)
Nicola Richmond (Exscientia)
Maria Brbic (EPFL)
Mo Lotfollahi (Wellcome Sanger Institute, University of Cambridge)
Xiner Li (Texas A&M University)
Ehsan Hajiramezanali (Genentech)
Student ORGANIZERS
Student ORGANIZERS
Tingyang YU (EPFL)
Yanay Rosen (Stanford)
Shuyang Fan (EPFL)
Lisa Marie Milchsack (Wellcome Sanger Institute)
Amirhossein Vahidi (Wellcome Sanger Instiute)
senior advisory boards
senior advisory boards
Aviv Regev (Genentech)
Sergey Levine (UC Berkeley)
SPONSORS
SPONSORS
Page updated
Google Sites
Report abuse